| Patient | Albert Einstein |
|---|---|
| Date of birth | 1956-03-14 |
| Identifiers | MRN HR-ET012-SYN; SSN (made up) 000-12-6650 |
| Document date | 2026-08-25 |
| Author | Clementine Ward, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Subsequent annual wellness visit; no new complaints. [S]
Mr. Einstein is a 70-year-old man with a 5.0 cm abdominal aortic aneurysm under surveillance, hypertension, and aortic atherosclerosis, who comes for his subsequent annual wellness visit six weeks after his three-month review. He completed the health risk assessment himself. The back strain in June settled within ten days. He has had no tobacco since his quit date in the spring, now uses the 7 mg patch and an occasional lozenge, and still sometimes holds an empty, unlit pipe while he thinks. His home blood pressure readings average 122/74. He takes amlodipine, losartan, atorvastatin, and aspirin without side effects. He walks to and from his office most days and has had no falls, emergency visits, or hospital stays this year. [S]
| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit |
| Active conditions | Abdominal aortic aneurysm under surveillance; hypertension; aortic atherosclerosis; nicotine dependence in early remission |
| Medicines | Amlodipine 5 mg, losartan 100 mg, atorvastatin 40 mg, aspirin 81 mg, nicotine 7 mg patch, nicotine lozenges as needed |
| Safety events | No falls, emergency visits, or hospital stays this year |
| Functional status | Independent in all daily activities |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, in his words |
| Psychosocial | Lives at home; works most days with colleagues; no loneliness |
| Tobacco | No tobacco since his quit date in the spring; on a nicotine patch |
| Alcohol | An occasional glass of wine (AUDIT-C 1) |
| Physical activity | Walks about an hour a day |
| Nutrition | Irregular meals when absorbed in work; less salt since the spring |
| Sleep | Sleeps well |
| Activities of daily living | Independent |
| Instrumental activities of daily living | Independent, including medicines and finances |
| Home safety | No firearms; smoke detectors working; no loose rugs |
| Falls | No falls this year |
| Hearing and vision | Reading glasses; no hearing concern; no eye examination in the past two years |
| Memory | No concerns |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever or fatigue |
| Eyes | Negative | No change in vision with reading glasses |
| Ears, nose, mouth, and throat | Negative | No hearing difficulty |
| Cardiovascular | Negative | No chest pain, palpitations, ankle swelling, or leg pain on walking |
| Respiratory | Negative | Morning cough gone since he stopped smoking; no breathlessness |
| Gastrointestinal | Negative | No abdominal pain, bleeding, or change in bowel habit |
| Genitourinary | Negative | Gets up once a night to pass urine; good stream |
| Musculoskeletal | Negative | Back strain resolved; no muscle aches on atorvastatin |
| Integumentary | Negative | No skin irritation from the patch beyond mild redness at the site |
| Neurological | Negative | No weakness, numbness, or memory concern |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |
| Hematologic | Negative | No easy bruising or bleeding on aspirin |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2025-05-20 | active | S |
| Losartan 50 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2026-03-24 to 2026-04-21 | completed | S |
| Losartan 100 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2026-04-21 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet by mouth each evening | Oral route | 2026-03-24 | active | S |
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet by mouth daily with food | Oral route | 2026-04-21 | active | S |
| Nicotine 14 mg/24 hour transdermal patch, one patch daily | Apply one new patch each morning | Topical route | 2026-03-24 to 2026-07-14 | completed | S |
| Nicotine 7 mg/24 hour transdermal patch, one patch daily | Apply one new patch each morning | Topical route | 2026-07-14 to 2026-09-22 | completed | S |
| Nicotine 2 mg lozenge as needed for cravings | Dissolve one lozenge in the mouth for a craving, no more often than every 2 hours and no more than 20 a day | Oral route | 2026-03-24 to 2026-09-22 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-25 | Body height | 172 | cm | S |
| 2026-08-25 | Body weight | 79.6 | kg | S |
| 2026-08-25 | Body mass index (BMI) [Ratio] | 26.9 | kg/m2 | S |
| 2026-08-25 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-08-25 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-08-25 | Heart rate | 66 | /min | S |
| 2026-08-25 | Respiratory rate | 14 | /min | S |
| 2026-08-25 | Body temperature | 36.6 | Cel | S |
| 2026-08-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-25 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-08-25 | Total score [AUDIT-C] | 1 | {score} | S |
Vital signs recorded on 2026-08-25; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well, alert, and engaged; weight 79.6 kg, BMI 26.9 |
| Eyes | Pupils equal and reactive; near vision 20/30 with reading glasses |
| Ears | Canals clear; whispered-voice test passed in both ears |
| Neck | No thyroid enlargement or nodes; no carotid bruits |
| Cardiovascular | Regular rhythm at 66 per minute; no murmur; blood pressure 124/74 mmHg; femoral, popliteal, and foot pulses normal |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; pulsatile mass above the umbilicus, non-tender; healed midline scar |
| Musculoskeletal | Timed Up and Go 9 seconds; rises from a chair without using his arms |
| Neurological | Alert and oriented; fluent, precise conversation; no focal deficit. Cognition assessed by direct observation |
| Psychiatric | Good humor; engaged |
| Skin | Mild redness at the current patch site; no suspicious lesions |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Infrarenal abdominal aortic aneurysm, 5.0 cm by duplex ultrasound, found and wrapped at a prior exploratory laparotomy; under surveillance below the repair threshold | active | confirmed | I71.43 | S — Synthetic modern coding anchored to the documented aneurysm found and wrapped at his exploratory laparotomy; the diameter and all surveillance are synthetic. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic risk factor in the modern frame; no historical blood pressure is documented in the cited sources. |
| Nicotine dependence, pipe tobacco | active | confirmed | F17.290 | S — Synthetic modern coding anchored to his documented pipe smoking. |
| Atherosclerosis of the abdominal aorta, with calcified atheroma on CT angiography | active | confirmed | I70.0 | S — Synthetic finding on the baseline CT angiography. |
| Acute low back strain after lifting, with aneurysm symptoms excluded; resolved | resolved | confirmed | S39.012A | S — Synthetic intercurrent illness at an unscheduled visit, chosen to teach how new back pain is assessed in a patient with a known aneurysm. It does not echo a documented illness. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, this season | Due | High-dose vaccine recommended at 65 and older; due when this season's vaccine arrives next month |
| Pneumococcal vaccine | Completed today | PCV20 given today; no further doses needed |
| Recombinant zoster vaccine | Completed today | Dose 1 given today; dose 2 due in two to six months |
| Tetanus, diphtheria, and pertussis booster | Due | No dose on record in the past ten years; to be given with the second zoster dose |
| COVID-19 vaccine, this season | Due | Recommended at his age; to be given with the influenza vaccine |
| RSV vaccine | Not indicated | Recommended at 75 and older, and from 50 with conditions that raise the risk of severe RSV disease; he has none. Review at 75 |
| Depression screening | Completed today | PHQ-2 score 0 |
| Alcohol misuse screening | Completed today | AUDIT-C score 1 |
| Tobacco use and cessation | Completed today | Tobacco-free since the spring; nicotine replacement continues to the six-month visit |
| Cognitive assessment | Completed today | Direct observation and his own report; no concern |
| Falls prevention | Completed today | Timed Up and Go 9 seconds; no falls; daily walking continues |
| Hearing | Completed today | Whispered-voice test passed in both ears |
| Eye examination | Due | No eye examination in the past two years; a yearly examination is part of his hypertension monitoring; appointment to be booked |
| Cholesterol and statin | Up to date | On atorvastatin 40 mg; LDL 62 mg/dL six weeks ago |
| Diabetes screening | Up to date | HbA1c 5.6 percent in March; repeat yearly |
| Blood pressure | Completed today | 124/74 mmHg; home average 122/74 |
| Abdominal aortic aneurysm screening | Not indicated | Screening is for men 65 to 75 who have ever smoked; he already has a known aneurysm under surveillance |
| Lung cancer screening | Not indicated | The criteria are based on cigarette pack-years; he smoked only a pipe, so he does not meet them. He was told to report a persistent cough, blood in the sputum, or weight loss |
| Colorectal cancer screening | Ordered | No screening on record in the past ten years; at 70 and in good health he chose a fecal immunochemical test, and a kit was given today |
| Prostate cancer screening | Not indicated | PSA screening is not recommended at 70 and older |
| Hepatitis C screening | Ordered | One-time screening for adults 18 to 79; no result on record; ordered with his consent |
| Advance care planning | Completed today | Health care agent form completed; values recorded |
Immunizations given today: Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]
Guideline basis: CMID: Clinical Monitoring Intelligence Database, Hypertension and Hyperlipidemia monographs (2026); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Six-month aneurysm surveillance visit with duplex ultrasound in four weeks. Influenza and COVID-19 vaccines next month. Second zoster dose and Tdap in two to six months. Return the stool test kit within two weeks; the hepatitis C result will be sent by letter. Next annual wellness visit in one year. Next scheduled visit 2026-09-22: six-month aneurysm surveillance with duplex ultrasound. [S]
Advance care planning was discussed as part of the wellness visit. He completed a health care agent form; the agent is recorded in the chart and not named here. He said that he wants to make his own medical decisions for as long as he can, with plain numbers in front of him, and that what matters most to him is being able to keep working and walking. On the aneurysm, he repeated what he agreed with vascular surgery in April: he would consider endovascular repair if it reaches the threshold, and wants the decision reviewed with him at each scan rather than settled in advance. No treatment limits were recorded, and he will revisit the plan at next year's visit or sooner if his health changes. [S]